Immucell (ICCC) Stock: Buy, Sell, or Hold?
ICCC - Immucell Corp
$9.60
-0.20 (-2.04%)
▼
5d:
-3.71%
30d:
-3.23%
90d:
-6.71%
WAIT
LOW Confidence
Analysis Updated: Sep 30, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ICCC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ICCC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $9.60, which is considered oversold relative to its 30-day fair value range of $9.76 to $10.02.
Technical Outlook: Technically, ICCC is showing sideways momentum. The price is currently testing key support at $9.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.00 (+42.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICCC is showing sideways momentum. The price is currently testing key support at $9.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.00 (+42.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.76 -
$10.02
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.9% below Wall St target ($14.00)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.76 -
$10.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.55
Resistance Level
$10.16
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Wall Street Target
$14.00
(+42.9%)
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
259.9%
Profit Margin
2.6%
Share & Embed Analysis
Last updated: October 01, 2026 4:08 PM ET
Data refreshes hourly during market hours. Next update: 5:08 PM
Data refreshes hourly during market hours. Next update: 5:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 51 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 45 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 61 BUY |
